The cold-chain myth: what the science says
There is a widespread belief that every peptide shipment must travel on ice or the material is ruined. For a dry, lyophilized powder this is largely untrue. Studies of biomolecule stability consistently show that peptides and proteins are markedly more stable in the solid state than in solution (Chen et al., 2021). Brief heat exposure during transit – for example several days at 30–45 °C in a mailbox – generally does not cause meaningful degradation of a dry powder. This does not mean temperature never matters; it means a missing ice pack is not, by itself, the dominant risk factor for lyophilized material. The real questions lie elsewhere – in moisture and packaging integrity.
Water is the main culprit: hydrolysis as the key degradation pathway
The principal chemical degradation routes for peptides – hydrolysis of the peptide bond, deamidation of asparagine and glutamine, and aggregation – largely require water. Hydrolysis is literally the cleavage of a peptide bond by a water molecule; without water, this reaction essentially cannot proceed. This is precisely why lyophilization removes water and lowers water activity, halting the hydrolytic and mobility-driven processes (Cicerone et al., 2015). In a glassy, dry matrix the mobility of reactive species is strongly restricted, so oxidation and aggregation also slow dramatically. The key conclusion for logistics: if the powder is dry and stays dry, the primary driver of degradation – water – is simply absent, regardless of how warm it is outside.
Why dry lyophilized powder tolerates heat during transit
Reaction rates do rise with temperature, often described by the Arrhenius equation, but the baseline degradation rate in the dry solid state is already extremely low. So moderate heating of a very small baseline rate still means a small absolute loss over a few days of transit. Reviews of protein solids stress that the critical parameter is the matrix glass transition temperature (Tg); as long as the material stays below it and dry, it remains stable (Chen et al., 2021). It is also important that aggregation often does not follow a simple Arrhenius curve, so short heat excursions cannot be equated with prolonged high-temperature storage (Wang and Roberts, 2013). A few days in a warm parcel is not the same as months on a shelf at room temperature.
The real transit risks: moisture, seal, and desiccant
Because water is the main trigger of degradation, the real transit risks concern moisture ingress rather than heat. Lyophilized peptides are hygroscopic – they absorb water from the air – and even trace moisture can restart hydrolysis and aggregation. Solid-state studies show this vividly: a control sample at 0% relative humidity and 50 °C remained almost unchanged, while the same protein at high humidity rapidly aggregated and lost activity (Flores-Fernández et al., 2010). The critical factors are therefore the integrity of the vial seal, an undamaged stopper, and the presence of a desiccant in the package. A cracked vial, a loosened stopper, or a broken seal is a far more serious problem than a warm mailbox.
What to check when the shipment arrives
On arrival, your inspection should focus not on whether the parcel was warm, but on signs of moisture ingress and damage. Confirm that the vial is intact, the stopper is firmly seated, and the factory seal is undisturbed. The powder or pellet should be dry, white to off-white and free-flowing; signs that the peptide has taken up moisture include a sticky, oily, or partially dissolved appearance at the bottom of the vial. Check that any desiccant included in the packaging was present and intact. A dry, fully sealed powder accompanied by its certificate of analysis (COA) is a reliable indication that the material stayed in its intended state in transit. If in doubt, store the material as directed and consult the batch COA.
Where cold really matters: after reconstitution and for long-term storage
The message here is not that temperature never matters – it is about when. Once a peptide is reconstituted into a solution for bench work, all water-driven processes – hydrolysis, deamidation, oxidation and aggregation – restart, so the solution is far less stable than the dry powder and should be kept cold and used promptly. The same applies to long-term storage of stock: lyophilized material is generally held frozen for months or years, because even slow solid-state reactions add up over time. The distinction, then, is between a few days of transit of a dry powder, which tolerates heat, and long-term storage or a solution, where cold genuinely extends stability.
Research use only
This content is educational and concerns reagent logistics and stability; it is not medical, clinical, or dosing advice. All peptides on peptid.si are intended strictly for research use only (RUO) and are not for human or veterinary use, nutrition, or use as a medicine. peptid.si supplies material sealed and lyophilized, with laboratory-verified purity and a publicly available certificate of analysis (COA) for every batch. Before purchasing or using material in research, review the relevant batch COA in our COA Vault to confirm the identity and purity of the material you received.
References / Links
- Cicerone MT, Pikal MJ, Qian KK (2015). Stabilization of proteins in solid form. Advanced Drug Delivery Reviews. PubMed
- Chen Y, Mutukuri TT, Wilson NE, Zhou QT (2021). Pharmaceutical protein solids: Drying technology, solid-state characterization and stability. Advanced Drug Delivery Reviews. PubMed
- Flores-Fernández GM, Pagán M, Almenas M, Solá RJ, et al. (2010). Moisture-induced solid state instabilities in α-chymotrypsin and their reduction through chemical glycosylation. BMC Biotechnology. PubMed
- Wang W, Roberts CJ (2013). Non-Arrhenius protein aggregation. The AAPS Journal. PubMed
